longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CERO THERAPEUTICS HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM)

CEROW

0.00280.00% ( 0.0000 )
Delay Closed: Sep 10, 16:00:00 (EDT)
Start trading
OverviewOverviewNewsNewsPostsPosts
LongbridgeAI
  • Precision Medicine Has a Commercialization Problem

    Fiercepharma·17 hours ago
    BMRN+1.71%
  • CAMP: Phase I trial for SYNGAP1 to launch in Q4, leveraging global sites and robust preclinical data

    Quartr·1 day ago, 06:50 PM
  • Actuate reports preclinical synergy of elraglusib with RAS inhibitors in pancreatic cancer models

    PUBT·1 day ago, 11:10 AM
    ACTU-8.73%
  • AI | Google DeepMind Model Predicts 9 Billion DNA Changes

    CoinLive·1 day ago, 11:05 AM
    GGLL+1.10%GGLS-0.56%
  • Can-Fite Biopharma GAAP EPS of -$1.24, revenue of $0.2M

    businessinsider·2 days ago, 05:15 AM
    CANF-1.37%
  • Pricing policy ‘earthquake’ forcing commercial rethink: survey

    Fiercepharma·2 days ago, 04:02 AM
  • QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy

    Quartr·2 days ago, 09:05 PM
    QTTB-3.77%
  • Royalty Pharma shares are trading lower amid sympathy with Novartis after that company's pelacarsen phase III trial failed to reach its primary endpoint. The company had signed a $500 million funding agreement with Novartis partner Ionis that would have contributed pelacarsen royalties.

    benzinga_article·2 days ago, 02:48 PM
    NVS0.00%RPRX-3.04%
  • Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders | DTCFF Stock News

    StockTitan·Sep 7 at 11:15 PM
  • Promising Pharmaceutical Stocks To Follow Now - September 4th

    Market Beat·Sep 4 at 06:01 PM
    - MarketBeat's stock screener has identified 7 pharmaceutical stocks with the highest dollar trading volume over the past several days. - The featured companies include Eli Lilly and Company, Johnson & Johnson, AbbVie, McKesson, Abbott Laboratories, Pfizer, and Merck & Co., Inc. - These stocks represent major businesses in drug discovery, development, and healthcare services that are influenced by clinical trials, regulatory approvals, and market demand.
    MCK-1.21%ABBV+1.63%
  • CERO THERAPEUTICS HOLDINGS INC C/WTS 14/02/2029 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

    Earnings Watch·Nov 19, 2025 at 09:12 PM
    CEROW0.00%
  • CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/2029 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -61.71

    Earnings Watch·Aug 22, 2025 at 08:08 PM
    CEROW0.00%
  • CERO THERAPEUTICS HOLDINGS INC C/WTS 13/02/2029 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -1.59

    Earnings Watch·May 15, 2025 at 08:59 PM
    CEROW0.00%